"Aclarubicin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An anthracycline produced by Streptomyces galilaeus. It has potent antineoplastic activity.
| Descriptor ID |
D015250
|
| MeSH Number(s) |
D02.455.426.559.847.562.050.050 D04.615.562.050.050 D09.408.051.059.050
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aclarubicin".
Below are MeSH descriptors whose meaning is more specific than "Aclarubicin".
This graph shows the total number of publications written about "Aclarubicin" by people in this website by year, and whether "Aclarubicin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aclarubicin" by people in Profiles.
-
Wang HF, Figueiredo Pereira ME, Correia MA. Cytochrome P450 3A degradation in isolated rat hepatocytes: 26S proteasome inhibitors as probes. Arch Biochem Biophys. 1999 May 01; 365(1):45-53.
-
Figueiredo-Pereira ME, Chen WE, Li J, Johdo O. The antitumor drug aclacinomycin A, which inhibits the degradation of ubiquitinated proteins, shows selectivity for the chymotrypsin-like activity of the bovine pituitary 20 S proteasome. J Biol Chem. 1996 Jul 12; 271(28):16455-9.